Lung Transplantation
Lung Transplant is surgery to replace one or both diseased lungs with healthy lungs from a human donor. In most cases, the new lung or Lungs are usually donated by a person who is under age 65 and brain-dead, but is still on life-support. The donor tissue must be matched as closely as possible to your tissue type. This reduces the chance that the body will reject the transplant. Lungs can also be given by living donors. Two or more people are needed. Each person donates a segment (lobe) of their Lung Diseases. This forms an entire lung for the person who is receiving it. During Lung Transplant Surgery, you are asleep and pain-free (under general Anesthesia). A surgical cut is made in the chest. Lung Transplant surgery is often done with the use of a heart-Lung Machine. This device does the work of your heart and lungs while your heart and lungs are stopped for the Surgery.
- Post-operative care and Statistics of Transplantation
- Eosinophilic Granuloma
- Chronic Lung Transplantation
- Lung Transplantation Cystic fibrosis
- Lung Rejection
- Bronchiectasis and Lymphangioleiomyomatosis (LAM)
Related Conference of Lung Transplantation
15th International Conference on Pulmonary & Respiratory Medicine
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Lung Transplantation Conference Speakers
Recommended Sessions
- Advanced Respiratory Equipment
- Advances in Respiratory Medicine
- Asthma
- Cardiopulmonary Disorders
- COPD
- Effect of Smoking
- Lung Cancer
- Lung Transplantation
- Prevention of Lung Disorders
- Pulmonary Fibrosis and Cystic Fibrosis
- Respiratory and Pulmonary Therapies
- Respiratory Diseases
- Respiratory diseases in children and infants
- Respiratory Tract Infections
- Sleep Apnea
- Tuberculosis
Related Journals
Are you interested in
- Advancements in Pulmonary Diagnostics - Respiratory 2024 (France)
- Asthma - Tuberculosis-2024 (France)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Cardio Pulmonary Disorders - Respiratory 2024 (France)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic Obstructive Pulmonary Disease - Respiratory 2024 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- COVID-19 and Asthma - Respiratory 2024 (France)
- COVID-19 and Respiratory System - Respiratory 2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Idiopathic Pulmonary Fibrosis - Respiratory 2024 (France)
- Interstitial Lung Disease - Respiratory 2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung Cancer - Respiratory 2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung Transplantation - Respiratory 2024 (France)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Obstructive Sleep Apnea - Respiratory 2024 (France)
- Occupational Lung Diseases - Respiratory 2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pneumonia - Respiratory 2024 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary diseases: Treatment, Diagnosis and therapies - Respiratory 2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary Hypertension - Respiratory 2024 (France)
- Pulmonary Rehabilitation - Respiratory 2024 (France)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Tuberculosis - Respiratory 2024 (France)
- Zoonotic TB - Tuberculosis-2024 (France)